News & Articles

Scientists have discovered a molecule that could aid the development of new treatments for MND

Integrating the Compresstome Vibrating Microtome into the Agilent Seahorse XF Flex tissue workflow

Two new partnerships enhance QIAGEN’s capabilities to support pharma partner clinical trials with significant expansion of MRD capabilities, especially using QIAcuity digital PCR

SB000 reverses cellular ageing as measured by DNA methylation clocks in multiple cell types without loss of cellular identity or signs of pluripotency

Supported by 50 years of spectroscopy expertise, this subdivision aims to "deliver accuracy, consistency, and insight"

This collaboration aims to expand metabolite and lipid analysis through the power of mass spectrometry

New analytical instruments and innovative software to drive breakthroughs in biopharmaceutical discovery, translational omics and safer water quality

Three interrelated Body of Knowledge papers outline roles and required skills for bioinformaticians with respect to molecular diagnostics, clinical bioinformatics, clinical laboratory regulation and data security

Collaboration allows researchers to progress rapidly from DNA to purified and characterized protein, to facilitate insights into drug-target interactions

Over 200 exhibitors, AI-powered breakthroughs, and strategic forums set to transform regional healthcare

How cross-disciplinary collaboration and earlier recognition can transform outcomes for patients with Crohn’s disease and ulcerative colitis

The partnership aims to support cell therapy researchers with a standardized and reliable MSC reference system

The ORCA-Halo combines cutting-edge reliable technology with excellent image quality performance

A key focus of the partnership will be the development of adeno-associated virus gene therapy programs using intellectual property from KU Leuven

Waters has acquired Halo Labs™ to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies

The new site is still within the Midlothian Science Zone and is now fully operational, marking a significant milestone in the company’s continued growth

Licensing with a global enzyme provider for two Optimer reagents in research and diagnostics

New solutions from Siemens Healthineers address labs’ environmental and efficiency goals

BUCHI sets a new standard in material analysis, offering tailored solutions for quality assurance at every stage of the supply chain

The acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases

Data to be presented as a late-breaking abstract at the 2025 European Society for Medical Oncology (ESMO) Breast Cancer Congress

A study by Karl Landsteiner University of Health Sciences shows that higher radiation doses in lung cancer treatment carry no added risk of inflammation and may improve survival

New solutions support high-precision analytics for process development, batch release and regulatory compliance and enable a standardized workflow

1 in 3 Phase II trials were terminated in 2024